SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue 5, Pages 1025-1032
Publisher
Oxford University Press (OUP)
Online
2014-02-22
DOI
10.1093/annonc/mdu084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- European cancer mortality predictions for the year 2013
- (2013) M. Malvezzi et al. ANNALS OF ONCOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
- (2013) Wei-Chih Liao et al. LANCET ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the Ras–ERK pathway in pancreatic adenocarcinoma
- (2012) Cindy Neuzillet et al. CANCER AND METASTASIS REVIEWS
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Diverse biological functions of the SPARC family of proteins
- (2012) Amy D. Bradshaw INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Keys to Personalized Care in Pancreatic Oncology
- (2012) Christopher H. Crane et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
- (2010) Tine S. Mantoni et al. CANCER BIOLOGY & THERAPY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer
- (2010) Jun Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
- (2009) S. A. Arnold et al. Disease Models & Mechanisms
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started